The Collaboration’s funders

We do not accept commercial or conflicted funding – this is vital for us to generate authoritative and reliable information, produced by people who can work freely, unconstrained by commercial and financial interests."
 CEO

The Cochrane Collaboration’s funding model reflects the international and dispersed nature of the organisation. While our core income (income paid directly to the Collaboration and used to sustain its information management system, research programmes, website etc) comes principally from the proceeds of The Cochrane Library and other Cochrane products, our groups - known as 'entities' - are supported by national governments, international governmental and non-governmental organisations, universities, hospitals, private foundations, and personal donations. They are not permitted to accept funding from commercial organisations such as pharmaceutical companies. This is to ensure that the conclusions of Cochrane Reviews are not influenced by commercial interests.

Read more about our policy on commercial sponsorship here.

The Collaboration wishes to thank the following for their support:

  • Argentina, Instituto de Efectividad Clínica y Sanitaria
  • Arturo Martí-Carvajal
  • Australia, Children's Hospital at Westmead
  • Australia, Commonwealth Department of Health and Ageing
  • Australia, Department of Health, Victoria
  • Australia, Joanna Briggs Institute, Adelaide
  • Australia, Queensland Health
  • Australia, South West Sydney Local Health Network
  • Australia, University of Sydney
  • Australia, Victorian Health Promotion Foundation
  • Austria, Danube University Krems
  • Austria, State Government of Lower Austria
  • Bahrain, AMA International University Bahrain
  • Belgium, Ministry of Health
  • Brazil, EBM Research Centre/Faculties
  • Brazil, Federal Agency for the Support and Evaluation of Graduate Education (CAPES)
  • Brazil, Paulista Association for the Development of Medicine (SPDM)
  • Bruce and Sue Shepherd
  • Canada, CIHR Institute of Cancer
  • Canada, Canadian Institutes of Health Research (CIHR)
  • Canada, Center for Global Health, Institution for Population Health, Ottawa
  • Canada, CIHR Institute of Circulatory and Respiratory Health
  • Canada, CIHR Institute of Gender and Health
  • Canada, CIHR Institute of Health Services and Policy Research
  • Canada, CIHR Institute of Musculoskeletal Health and Arthritis
  • Canada, CIHR Institute of Nutrition, Metabolism and Diabetes
  • Canada, CIHR Strategy for Patient-Oriented Research
  • Canada, Institute for Work & Health
  • Canada, McMaster funds
  • Canada, Ministry of Health
  • Canada, Ministry of Health-LTC, Ontario
  • Canada, Nova Scotia Health Research Foundation
  • Canada, Ontario Ministry of Health and Long-term Care (Excellent Care for All Strategy)
  • Canada, Ottawa Hospital Research Institute (OHRI)
  • Canadian Chiropractic Association
  • Canadian Chiropractic Examining Board
  • Canadian Chiropractic Protective Association
  • Chile, Universidad Católica de Chile
  • Costa Rica, IHCAI Foundation
  • Croatia, City of Split
  • Croatia, School of Medicine, Split
  • Croatia, Split and Dalmatia County
  • Denmark, Copenhagen Hospital Corporation
  • Denmark, Danish Government
  • Denmark, Region Hovedstaden, Copenhagen
  • European Society of Anaesthesiology (ESA)
  • European Union
  • Finland , Finnish Institute of Occupational Health
  • Finland, National Institute for Health and Welfare
  • France, Ecole des Hautes Etudes en Santé Publique (EHESP)
  • France, Haute Autorité de Santé (HAS)
  • France, MAPI Research Trust
  • France, Ministry of Health
  • Germany, AOK Baden-Württemberg
  • Germany, Deutsche Krebshilfe e.V.
  • Germany, Federal Ministry of Education and Research
  • Germany, Heinrich-Heine University
  • Germany, Institute for Quality and Efficiency in Health Care - IQWiG
  • Germany, Köln Fortune/University of Cologne
  • Germany, Ministry of Health
  • Germany, University Hospital of Cologne
  • Germany, University Medical Center Freiburg
  • Hong Kong, School of Public Health and Primary Care (SPHPC)
  • India, Indian Council for Medical Research
  • India, Public Health Foundation of India
  • Ireland, Health Research Board
  • Italy, Association for Epidemiology Research for Neurological Disease (AREMAN)
  • Italy, Cabrini Institute, Cabrini Hospital
  • Italy, Fondazione I.R.C.C.S. Istituto Neurologico Besta
  • Italy, Hospital Galeazzi, Milan
  • Italy, Italian Drug Agency (AIFA)
  • Italy, Italian Multiple Sclerosis Federation (FISM)
  • Italy, Lazio Regional Health Authority
  • Italy, Mario Negri Institute
  • Italy, Ministry of Health
  • Italy, National Institute of Health
  • Italy, Regione Umbria Health Authority
  • Italy, Rete Regionale Allergologia
  • Italy, University of Milan
  • Italy, Voluntary Association for Multiple Sclerosis (AVASM) (ONLUS)
  • Korea, Health Industry Development Institute
  • Netherlands, Dutch Academic Departments of General Practice, the Dutch College of GPs and the Netherlands Institute for Health Services Research
  • Netherlands, Dutch Health Insurance Council
  • Netherlands, Leiden University Medical Center
  • Netherlands, Ministry of Health
  • Netherlands, Netherlands Trial Register
  • Netherlands, Royal Dutch Society for Physical Therapy (KNGF)
  • New Zealand, New Zealand Guidelines Group
  • Nigeria, Federal Ministry of Education/University of Calabar
  • Nigeria, University of Calabar Teaching Hospital/Federal Ministry of Health
  • Norway, Norwegian Agency for Development Cooperation (Norad)
  • Norway, Norwegian Government
  • Norway, Norwegian Knowledge Center for Health Services
  • PEARLS publication
  • People’s Republic of China, West China Hospital
  • Singapore, Duke-NUS Graduate Medical School
  • Singapore, National Medical Research Council
  • South Africa, Medical Research Council
  • Spain, Agencies for Health Technology Assessment (CAHIAQ, Catalunya - AETSA, Andalucía) and Guidelines Development
  • Spain, Fundación Sanitas
  • Spain, Hospital de la Santa Creu i Sant Pau
  • Spain, Ministry of Health (Instituto de Salud Carlos III)
  • Switzerland, Lausanne University Hospital (CHUV)
  • Thailand, Thailand Research Fund (TRF)
  • UK, Age-Related Diseases Trust
  • UK, Centre of Evidence Based Dermatology
  • UK, Department for International Development (DFID)
  • UK, Effective Healthcare Research Consortium
  • UK, Friends of Bath Oncology Charity Donation Funds
  • UK, Medical Research Council (MRC)
  • UK, National Blood Service
  • UK, National Institute for Health Research (NIHR)
  • UK, Newcastle University
  • UK, Oxford University
  • UK, Scottish Government Health Directorates, The Scottish Government
  • UK, Sightsavers International
  • UK, University of Birmingham
  • UK, University of East Anglia
  • UK, Welsh Assembly Government
  • US Department of Justice
  • US National Center for Complementary and Alternative Medicine (NCCAM)
  • US, Agency for Healthcare Research and Quality (AHRQ)
  • US, Blue Cross Blue Shield California
  • US, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • US, National Library of Medicine
  • US, Neuroscience Education Institute (NEI)
  • US, University of California, San Francisco
  • World Health Organization (WHO)

Copyright © The Cochrane Collaboration
Comments for improvement or correction are welcome.
Email: web@cochrane.org